5//SEC Filing
Q Therapeutics, Inc. 5
Accession 0001209191-16-098217
CIK 0001366541operating
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 6:02 PM ET
Size
5.5 KB
Accession
0001209191-16-098217
Insider Transaction Report
Form 5
Q Therapeutics, Inc.[NONE]
EPPSTEIN DEBORAH ANNE
CEO & President, Director
Transactions
- Award
Option to Purchase Common Stock
2015-09-09$0.70/sh+15,479$10,835→ 2,909,250 totalExercise: $0.70From: 2015-10-08Exp: 2025-09-08→ Common Stock (15,479 underlying)
Footnotes (1)
- [F1]All options were fully vested on December 31, 2015.
Documents
Issuer
Q Therapeutics, Inc.
CIK 0001366541
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001366541
Filing Metadata
- Form type
- 5
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 6:02 PM ET
- Size
- 5.5 KB